|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013216,
umls-concept:C0015252,
umls-concept:C0023884,
umls-concept:C0030705,
umls-concept:C0036525,
umls-concept:C0037688,
umls-concept:C0205373,
umls-concept:C0494165,
umls-concept:C0600688,
umls-concept:C0728940,
umls-concept:C1522484,
umls-concept:C1561451,
umls-concept:C2698872
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
1999-9-24
|
|
pubmed:abstractText |
Hepatic arteriovenous shunting in the metastatic liver reduces the advantages of intraarterial infusion of chemotherapeutic agents because of the passage of drugs into the systemic circulation. The aim of this study was to quantitatively assess spontaneous functional hepatic arteriovenous shunting in patients with liver metastases and to determine its implication in the increase in systemic toxic effects of intra-arterial infusion chemotherapy with floxuridine.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
30
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1112-8
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10406191-Adult,
pubmed-meshheading:10406191-Aged,
pubmed-meshheading:10406191-Analysis of Variance,
pubmed-meshheading:10406191-Antimetabolites, Antineoplastic,
pubmed-meshheading:10406191-Arteriovenous Shunt, Surgical,
pubmed-meshheading:10406191-Biological Availability,
pubmed-meshheading:10406191-Female,
pubmed-meshheading:10406191-Floxuridine,
pubmed-meshheading:10406191-Humans,
pubmed-meshheading:10406191-Infusions, Intra-Arterial,
pubmed-meshheading:10406191-Liver,
pubmed-meshheading:10406191-Liver Neoplasms,
pubmed-meshheading:10406191-Male,
pubmed-meshheading:10406191-Middle Aged,
pubmed-meshheading:10406191-Sorbitol
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
Sorbitol removal by the metastatic liver: a predictor of systemic toxicity of intra-arterial chemotherapy in patients with liver metastases.
|
|
pubmed:affiliation |
Division of General Medicine A, San Giovanni Battista Hospital, Turin, Italy.
|
|
pubmed:publicationType |
Journal Article
|
